These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1450091)

  • 1. A multicenter comparison of nicorandil and diltiazem on serum lipid, apolipoprotein, and lipoprotein levels in patients with ischemic heart disease.
    Sasaki J; Saeki Y; Kawasaki K; Umeno M; Ikeda K; Handa K; Arakawa K
    Cardiovasc Drugs Ther; 1992 Oct; 6(5):471-4. PubMed ID: 1450091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical profile of nicorandil: an overview of its hemodynamic properties and therapeutic efficacy.
    Krumenacker M; Roland E
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S93-102. PubMed ID: 1282184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind comparison of the long-term efficacy of a potassium channel opener and a calcium antagonist in stable angina pectoris.
    Guermonprez JL; Blin P; Peterlongo F
    Eur Heart J; 1993 Jul; 14 Suppl B():30-4. PubMed ID: 8370370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of antianginal activity of nicorandil, propranolol and diltiazem with reference to the antianginal mechanism.
    Kinoshita M; Hashimoto K; Ohbayashi Y; Inoue T; Taguchi H; Mitsunami K
    Am J Cardiol; 1989 Jun; 63(21):71J-74J. PubMed ID: 2525330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety profile of an anti-anginal agent with potassium channel opening activity: an overview.
    Roland E
    Eur Heart J; 1993 Jul; 14 Suppl B():48-52. PubMed ID: 8370373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients.
    Döring G
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S74-81. PubMed ID: 1282180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of nicorandil on myocardial protection during coronary artery bypass grafting--a comparison with diltiazem].
    Okada K; Higami T; Ogawa K; Asada T; Mukohara N; Nishiwaki M; Sugimoto T; Kawamura T; Sakata M
    Nihon Kyobu Geka Gakkai Zasshi; 1992 Aug; 40(8):1225-32. PubMed ID: 1402165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the efficacy of nicorandil in patients with ischemic heart disease by exercise Tl-201 myocardial SPECT.
    Yamazaki J; Iida M; Igarashi M; Hosoi H; Ishiguro S; Hou M; Morishita T; Nakano H; Yabe Y; Koyama N
    Int J Clin Pharmacol Ther; 1994 Apr; 32(4):183-91. PubMed ID: 8032578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of the efficacy of nicorandil in patients with ischaemic heart disease using Exercise-T1-201 myocardial tomography.
    Yamazaki J; Ohsawa H; Uchi T; Iida M; Nakano H; Hosoi H; Morishita T; Yabe Y; Koyama N; Komatsu H
    Eur J Clin Pharmacol; 1993; 44(3):211-7. PubMed ID: 8491233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of nicorandil and other antianginal drugs on myocardial pH in the ischemic dog heart.
    Abiko Y; Ichihara K; Sakai K
    J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S85-91. PubMed ID: 2447430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nicorandil on rest and effort angina unresponsive to combination therapy with a calcium antagonist and oral nitrate.
    Araki H; Hayata N; Matsuguchi T; Nakamura M
    Clin Ther; 1987; 9(2):174-82. PubMed ID: 2952276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potassium channel activators in the management of ischaemic heart disease: a focus on nicorandil.
    Purcell H; Fox K
    Br J Clin Pract; 1993; 47(3):150-4. PubMed ID: 8347442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind comparison of a beta-blocker and a potassium channel opener in exercise induced angina.
    Raftery EB; Lahiri A; Hughes LO; Rose EL
    Eur Heart J; 1993 Jul; 14 Suppl B():35-9. PubMed ID: 8370371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of KRN2391, nicorandil and diltiazem on the changes in the electrocardiogram caused by endothelin-1 in anaesthetized rats.
    Harada K; Miwa A; Kaneta S; Izawa T; Fukushima H; Ogawa N
    Br J Pharmacol; 1993 Jul; 109(3):679-84. PubMed ID: 7689399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of nicorandil and atenolol in stable angina pectoris.
    Hughes LO; Rose EL; Lahiri A; Raftery EB
    Am J Cardiol; 1990 Sep; 66(7):679-82. PubMed ID: 2144705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antianginal and anti-ischemic efficacy of nicorandil compared with nifedipine in patients with angina pectoris and coronary heart disease: a double-blind, randomized, multicenter study.
    Ulvenstam G; Diderholm E; Frithz G; Gudbrandsson T; Hedbäck B; Höglund C; Moelstad P; Perk J; Sverrisson JT
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S67-73. PubMed ID: 1282179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sinus arrest and severe peripheral vasodilation following cardiopulmonary bypass in a patient taking nicorandil.
    Montgomery H; Sumeray M; Carr C; Singer M
    Cardiovasc Drugs Ther; 1997 Mar; 11(1):81. PubMed ID: 9140682
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of nicorandil versus propranolol in mild stable angina pectoris of effort: a long-term, double-blind, randomized study.
    Meeter K; Kelder JC; Tijssen JG; Bucx JJ; Henneman JA; Kerker JP; Hugenholtz PG
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S59-66. PubMed ID: 1282178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potassium channel openers: clinical applications in ischemic heart disease--overview of clinical efficacy of nicorandil.
    Knight C; Purcell H; Fox K
    Cardiovasc Drugs Ther; 1995 Mar; 9 Suppl 2():229-36. PubMed ID: 7647027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of diltiazem sustained-release and captopril on blood pressure control and plasma lipoproteins in primary hypertension: a randomized, double-blind, crossover study.
    Lacourcière Y; Poirier L; Boucher S; Spenard J
    J Hum Hypertens; 1990 Oct; 4(5):553-6. PubMed ID: 2283645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.